OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell death, therapeutics, and the immune response in cancer
Kay Hänggi, Brian Ruffell
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 381-396
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Targeting ROS in cancer: rationale and strategies
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 583-606
Closed Access | Times Cited: 120

Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Pascal Meier, Arnaud J. Legrand, Dieter Adam, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 299-315
Closed Access | Times Cited: 105

Nanoparticle‐Based Photothermal Therapy for Breast Cancer Noninvasive Treatment
Yao Xiong, Yan Rao, Jiawei Hu, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 83

Cuproptosis: Harnessing Transition Metal for Cancer Therapy
Wuyin Wang, Wentao Mo, Zishan Hang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19581-19599
Closed Access | Times Cited: 82

Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada
Immunity (2023) Vol. 56, Iss. 10, pp. 2270-2295
Open Access | Times Cited: 50

Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis
Tianqi Ming, Jiarong Lei, Yu‐Hui Peng, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 3954-3972
Closed Access | Times Cited: 28

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Ying Feng, Zhibo Yang, Jianpeng Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19

Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 31

Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 15

Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 14

Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity
Yihong Wei, Wancheng Liu, Ruiqing Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 36-51
Closed Access | Times Cited: 13

PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer
Zitao Liu, Liang Sun, Xingyu Peng, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 799-815
Closed Access | Times Cited: 13

Beta-elemene: A phytochemical with promise as a drug candidate for tumor therapy and adjuvant tumor therapy
Yewen Feng, Qingwen An, Zhengqi Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116266-116266
Open Access | Times Cited: 13

Targeting ferroptosis: a new therapeutic opportunity for kidney diseases
Zhiyong Long, Yanfang Luo, Min Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9

Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication
Hua Wang, Tao Wang, Shuxiang Yan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9

Exploring the Therapeutic Potential of Ganoderma lucidum in Cancer
Gabriella Cancemi, Santino Caserta, Sebastiano Gangemi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1153-1153
Open Access | Times Cited: 8

Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8

The uptake of extracellular vesicles: research progress in cancer drug resistance and beyond
Luomeng Qian, Pangzhou Chen, Shiwu Zhang, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101209-101209
Closed Access | Times Cited: 1

Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis
Zihan Deng, Binghui Li, Muyang Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7

Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity
Kay Hänggi, Jie Li, Achintyan Gangadharan, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 6

Epigenetic regulation of pyroptosis in cancer: Molecular pathogenesis and targeting strategies
Ruonan Zhang, Zhi-Qian Jing, Lu Zhang, et al.
Cancer Letters (2023) Vol. 575, pp. 216413-216413
Open Access | Times Cited: 15

Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma
Wenqiong Chen, Yi He, Guowei Zhou, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron
Luwen Zhu, Yong‐Zhong Du
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124517-124517
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top